| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | semaphorin receptor activity | 8.45e-06 | 12 | 234 | 4 | GO:0017154 | |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 2.27e-05 | 15 | 234 | 4 | GO:0017081 | |
| GeneOntologyMolecularFunction | chloride channel inhibitor activity | 5.37e-05 | 7 | 234 | 3 | GO:0019869 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | HIPK1 STK32B RIOK3 PAK6 MAST2 SGK3 TTBK2 TESK2 CDC42BPG CDC42BPA PRKACG PRKD1 MAP3K21 MAPK10 | 1.04e-04 | 363 | 234 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | HIPK1 STK32B RIOK3 PAK6 ACVR2A MAST2 SGK3 TTBK2 TESK2 CDC42BPG CDC42BPA PRKACG PRKD1 MAP3K21 MAPK10 | 2.64e-04 | 446 | 234 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 4.07e-04 | 3 | 234 | 2 | GO:0070579 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.08e-05 | 13 | 238 | 4 | GO:0002116 | |
| Domain | Rho_GTPase_activation_prot | PLXNB2 PLXNA1 PLXNA2 RASAL2 ARAP2 PLXNA3 ARHGAP17 ARHGAP5 ARAP3 | 1.47e-06 | 88 | 232 | 9 | IPR008936 |
| Domain | Plexin_cytopl | 2.78e-06 | 9 | 232 | 4 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.78e-06 | 9 | 232 | 4 | IPR013548 | |
| Domain | Plexin | 2.78e-06 | 9 | 232 | 4 | IPR031148 | |
| Domain | PH_dom-like | MTMR10 FRMD4B MPRIP PLCL1 RASAL2 ARAP2 CDC42BPG CDC42BPA ASAP3 WDFY4 SPTBN4 ARAP3 TIAM1 PLEKHG3 PRKD1 CADPS2 TNS1 PHLDB2 | 6.73e-06 | 426 | 232 | 18 | IPR011993 |
| Domain | PINIT | 7.50e-06 | 4 | 232 | 3 | PS51466 | |
| Domain | PINIT | 7.50e-06 | 4 | 232 | 3 | PF14324 | |
| Domain | PINIT | 7.50e-06 | 4 | 232 | 3 | IPR023321 | |
| Domain | - | MTMR10 FRMD4B MPRIP PLCL1 RASAL2 ARAP2 CDC42BPG CDC42BPA ASAP3 SPTBN4 ARAP3 TIAM1 PLEKHG3 PRKD1 CADPS2 TNS1 PHLDB2 | 8.42e-06 | 391 | 232 | 17 | 2.30.29.30 |
| Domain | PH | MPRIP PLCL1 RASAL2 ARAP2 CDC42BPG CDC42BPA ASAP3 SPTBN4 ARAP3 TIAM1 PLEKHG3 PRKD1 CADPS2 PHLDB2 | 1.05e-05 | 278 | 232 | 14 | SM00233 |
| Domain | PH_DOMAIN | MPRIP PLCL1 RASAL2 ARAP2 CDC42BPG CDC42BPA ASAP3 SPTBN4 ARAP3 TIAM1 PLEKHG3 PRKD1 CADPS2 PHLDB2 | 1.10e-05 | 279 | 232 | 14 | PS50003 |
| Domain | PH_domain | MPRIP PLCL1 RASAL2 ARAP2 CDC42BPG CDC42BPA ASAP3 SPTBN4 ARAP3 TIAM1 PLEKHG3 PRKD1 CADPS2 PHLDB2 | 1.14e-05 | 280 | 232 | 14 | IPR001849 |
| Domain | PH | MPRIP ARAP2 CDC42BPG CDC42BPA ASAP3 SPTBN4 ARAP3 TIAM1 PLEKHG3 PRKD1 CADPS2 PHLDB2 | 3.08e-05 | 229 | 232 | 12 | PF00169 |
| Domain | TIG | 3.70e-05 | 31 | 232 | 5 | PF01833 | |
| Domain | IPT | 4.34e-05 | 32 | 232 | 5 | IPR002909 | |
| Domain | Ig_E-set | 4.65e-05 | 104 | 232 | 8 | IPR014756 | |
| Domain | zf-MIZ | 6.38e-05 | 7 | 232 | 3 | PF02891 | |
| Domain | ZF_SP_RING | 6.38e-05 | 7 | 232 | 3 | PS51044 | |
| Domain | Znf_MIZ | 1.01e-04 | 8 | 232 | 3 | IPR004181 | |
| Domain | - | 1.18e-04 | 21 | 232 | 4 | 1.10.720.30 | |
| Domain | SAP | 1.42e-04 | 22 | 232 | 4 | PF02037 | |
| Domain | Tet_JBP | 1.54e-04 | 2 | 232 | 2 | PF12851 | |
| Domain | 2OGFeDO_noxygenase_dom | 1.54e-04 | 2 | 232 | 2 | IPR024779 | |
| Domain | Tet_JBP | 1.54e-04 | 2 | 232 | 2 | SM01333 | |
| Domain | Kinase-like_dom | HIPK1 STK32B RIOK3 PAK6 ACVR2A MAST2 TRRAP SGK3 TTBK2 DST TESK2 CDC42BPG CDC42BPA PRKACG PRKD1 PEAK1 MAP3K21 MAPK10 | 1.56e-04 | 542 | 232 | 18 | IPR011009 |
| Domain | S_TKc | HIPK1 STK32B PAK6 ACVR2A MAST2 SGK3 TTBK2 CDC42BPG CDC42BPA PRKACG PRKD1 PEAK1 MAP3K21 MAPK10 | 1.68e-04 | 359 | 232 | 14 | SM00220 |
| Domain | SAP | 1.71e-04 | 23 | 232 | 4 | SM00513 | |
| Domain | ACTININ_2 | 1.71e-04 | 23 | 232 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.71e-04 | 23 | 232 | 4 | PS00019 | |
| Domain | - | 1.71e-04 | 23 | 232 | 4 | 3.40.50.10190 | |
| Domain | Actinin_actin-bd_CS | 1.71e-04 | 23 | 232 | 4 | IPR001589 | |
| Domain | IG_FLMN | 2.13e-04 | 10 | 232 | 3 | SM00557 | |
| Domain | SAP | 2.39e-04 | 25 | 232 | 4 | PS50800 | |
| Domain | SAP_dom | 2.39e-04 | 25 | 232 | 4 | IPR003034 | |
| Domain | BRCT | 2.80e-04 | 26 | 232 | 4 | PS50172 | |
| Domain | Filamin | 2.90e-04 | 11 | 232 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.90e-04 | 11 | 232 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.90e-04 | 11 | 232 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.90e-04 | 11 | 232 | 3 | IPR017868 | |
| Domain | Pkinase | HIPK1 STK32B PAK6 ACVR2A MAST2 SGK3 TTBK2 TESK2 CDC42BPG CDC42BPA PRKACG PRKD1 PEAK1 MAPK10 | 3.09e-04 | 381 | 232 | 14 | PF00069 |
| Domain | IPT | 3.25e-04 | 27 | 232 | 4 | SM00429 | |
| Domain | BRCT_dom | 3.76e-04 | 28 | 232 | 4 | IPR001357 | |
| Domain | Prot_kinase_dom | HIPK1 STK32B RIOK3 PAK6 ACVR2A MAST2 SGK3 TTBK2 TESK2 CDC42BPG CDC42BPA PRKACG PRKD1 PEAK1 MAP3K21 MAPK10 | 4.25e-04 | 489 | 232 | 16 | IPR000719 |
| Domain | RTT107_BRCT_5 | 4.57e-04 | 3 | 232 | 2 | PF16770 | |
| Domain | KINESIN_LIGHT | 4.57e-04 | 3 | 232 | 2 | PS01160 | |
| Domain | Kinesin_light_repeat | 4.57e-04 | 3 | 232 | 2 | IPR015792 | |
| Domain | PROTEIN_KINASE_DOM | HIPK1 STK32B RIOK3 PAK6 ACVR2A MAST2 SGK3 TTBK2 TESK2 CDC42BPG CDC42BPA PRKACG PRKD1 PEAK1 MAP3K21 MAPK10 | 4.65e-04 | 493 | 232 | 16 | PS50011 |
| Domain | Semap_dom | 5.61e-04 | 31 | 232 | 4 | IPR001627 | |
| Domain | SEMA | 5.61e-04 | 31 | 232 | 4 | PS51004 | |
| Domain | Sema | 5.61e-04 | 31 | 232 | 4 | SM00630 | |
| Domain | Sema | 5.61e-04 | 31 | 232 | 4 | PF01403 | |
| Domain | Dynein_HC_stalk | 6.22e-04 | 14 | 232 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.22e-04 | 14 | 232 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.22e-04 | 14 | 232 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.22e-04 | 14 | 232 | 3 | IPR011704 | |
| Domain | MT | 6.22e-04 | 14 | 232 | 3 | PF12777 | |
| Domain | AAA_5 | 6.22e-04 | 14 | 232 | 3 | PF07728 | |
| Domain | PROTEIN_KINASE_ST | HIPK1 STK32B PAK6 ACVR2A MAST2 SGK3 TTBK2 CDC42BPG CDC42BPA PRKACG PRKD1 MAP3K21 MAPK10 | 6.26e-04 | 362 | 232 | 13 | PS00108 |
| Domain | Plexin_repeat | 6.35e-04 | 32 | 232 | 4 | IPR002165 | |
| Domain | PSI | 6.35e-04 | 32 | 232 | 4 | PF01437 | |
| Domain | AGC-kinase_C | 6.46e-04 | 56 | 232 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 6.46e-04 | 56 | 232 | 5 | PS51285 | |
| Domain | S_TK_X | 6.46e-04 | 56 | 232 | 5 | SM00133 | |
| Domain | PROTEIN_KINASE_ATP | HIPK1 STK32B PAK6 ACVR2A MAST2 SGK3 TTBK2 TESK2 CDC42BPG CDC42BPA PRKACG PRKD1 PEAK1 MAP3K21 MAPK10 | 6.49e-04 | 459 | 232 | 15 | PS00107 |
| Domain | DHC_fam | 7.71e-04 | 15 | 232 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.71e-04 | 15 | 232 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.71e-04 | 15 | 232 | 3 | IPR004273 | |
| Domain | NIPSNAP | 9.07e-04 | 4 | 232 | 2 | IPR012577 | |
| Domain | Myotonic_dystrophy_kinase_coil | 9.07e-04 | 4 | 232 | 2 | IPR014930 | |
| Domain | Kinesin_light | 9.07e-04 | 4 | 232 | 2 | IPR002151 | |
| Domain | Myotonic_dystrophy_kinase_coil | 9.07e-04 | 4 | 232 | 2 | PD011252 | |
| Domain | DMPK_coil | 9.07e-04 | 4 | 232 | 2 | PF08826 | |
| Domain | NIPSNAP | 9.07e-04 | 4 | 232 | 2 | PF07978 | |
| Domain | - | 9.40e-04 | 16 | 232 | 3 | 1.10.506.10 | |
| Domain | C2_dom | 1.04e-03 | 164 | 232 | 8 | IPR000008 | |
| Domain | C2 | 1.26e-03 | 131 | 232 | 7 | PF00168 | |
| Domain | RasGAP_dom | 1.34e-03 | 18 | 232 | 3 | IPR001936 | |
| Domain | BRCT | 1.58e-03 | 19 | 232 | 3 | PF00533 | |
| Domain | C2 | 1.64e-03 | 137 | 232 | 7 | SM00239 | |
| Domain | Ser/Thr_kinase_AS | HIPK1 STK32B PAK6 ACVR2A MAST2 SGK3 CDC42BPG CDC42BPA PRKACG PRKD1 MAP3K21 MAPK10 | 1.76e-03 | 357 | 232 | 12 | IPR008271 |
| Domain | Pkinase_C | 1.79e-03 | 42 | 232 | 4 | PF00433 | |
| Domain | CRIB | 1.84e-03 | 20 | 232 | 3 | PS50108 | |
| Domain | C2 | 2.01e-03 | 142 | 232 | 7 | PS50004 | |
| Domain | CRIB_dom | 2.13e-03 | 21 | 232 | 3 | IPR000095 | |
| Domain | PSI | 2.13e-03 | 44 | 232 | 4 | IPR016201 | |
| Domain | AAA | 2.17e-03 | 144 | 232 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 2.17e-03 | 144 | 232 | 7 | IPR003593 | |
| Domain | DUF3398 | 2.23e-03 | 6 | 232 | 2 | PF11878 | |
| Domain | Rab5-bind | 2.23e-03 | 6 | 232 | 2 | PF09311 | |
| Domain | Rabaptin_Rab5-bd_dom | 2.23e-03 | 6 | 232 | 2 | IPR015390 | |
| Domain | TPR_10 | 2.23e-03 | 6 | 232 | 2 | PF13374 | |
| Domain | DOCK_C/D_N | 2.23e-03 | 6 | 232 | 2 | IPR021816 | |
| Domain | BRCT | 2.45e-03 | 22 | 232 | 3 | SM00292 | |
| Domain | PSI | 2.52e-03 | 46 | 232 | 4 | SM00423 | |
| Domain | PDZ | 2.84e-03 | 151 | 232 | 7 | PS50106 | |
| Domain | PDZ | 2.94e-03 | 152 | 232 | 7 | IPR001478 | |
| Domain | Dimeric_a/b-barrel | 3.10e-03 | 7 | 232 | 2 | IPR011008 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | CFTR NIPSNAP2 PAK6 DST SCFD1 DOCK6 PLXNA1 RASAL2 ARAP2 CDC42BPA ESYT1 ARHGAP17 CCT2 LETM1 ARHGAP5 ARAP3 TIAM1 PLEKHG3 DOCK7 PEAK1 | 1.76e-06 | 450 | 184 | 20 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | PPP1R12A CFTR NIPSNAP2 PAK6 DST SCFD1 DOCK6 PLXNA1 RASAL2 KLC1 ARAP2 CDC42BPA ESYT1 NUP98 KLC2 ARHGAP17 CCT2 LETM1 ARHGAP5 PPP2R5B ARAP3 TIAM1 PLEKHG3 DOCK7 PEAK1 KDM1A | 2.32e-06 | 720 | 184 | 26 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | PPP1R12A CFTR NIPSNAP2 PAK6 DST SCFD1 DOCK6 PLXNA1 RASAL2 KLC1 ARAP2 CDC42BPA ESYT1 NUP98 KLC2 ARHGAP17 CCT2 LETM1 ARHGAP5 PPP2R5B ARAP3 PLEKHG3 DOCK7 PEAK1 | 3.94e-06 | 649 | 184 | 24 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | CFTR NIPSNAP2 PAK6 DST SCFD1 DOCK6 PLXNA1 RASAL2 ARAP2 CDC42BPA ESYT1 ARHGAP17 CCT2 LETM1 ARHGAP5 ARAP3 PLEKHG3 DOCK7 PEAK1 | 4.77e-06 | 439 | 184 | 19 | MM15595 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | PAK6 DOCK6 ARAP2 CDC42BPA ESYT1 ARHGAP17 ARHGAP5 ARAP3 TIAM1 PLEKHG3 DOCK7 | 2.97e-05 | 184 | 184 | 11 | M41809 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | PAK6 DOCK6 ARAP2 CDC42BPA ARHGAP17 ARHGAP5 ARAP3 TIAM1 PLEKHG3 DOCK7 | 3.60e-05 | 155 | 184 | 10 | M41808 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | PAK6 DOCK6 ARAP2 CDC42BPA ESYT1 ARHGAP17 ARHGAP5 ARAP3 PLEKHG3 DOCK7 | 1.00e-04 | 175 | 184 | 10 | MM15599 |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.73e-04 | 9 | 184 | 3 | MM15030 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.85e-04 | 91 | 184 | 7 | M39700 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.27e-04 | 94 | 184 | 7 | MM15598 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 PPP1R12A SPIRE1 PAK6 MAST2 MPRIP FSIP2 USP31 DST TESK2 DOCK6 RASAL2 KLC1 ARAP2 CDC42BPA NELFCD ESYT1 GTSE1 KLC2 ARHGAP17 RESF1 TIAM1 PLEKHG3 SIPA1L1 TET1 DOCK7 PEAK1 MAP3K21 KIF13A ATP2B1 PHLDB2 | 6.91e-14 | 861 | 240 | 31 | 36931259 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIFBP IRF2BP1 IFT172 PPP1R12A SPIRE1 TIPRL MPRIP LRRC47 GLI3 TESK2 POLL SPAG16 NMT1 CLUH RASAL2 KLC1 VTI1B GLRX3 ESYT1 NIPSNAP1 SHOC2 CREBBP MRPL39 TIAM1 RDH11 SIPA1L1 DOCK7 PRKD1 EXOC2 MAP3K21 GGA1 KDM1A PHLDB2 | 1.88e-10 | 1321 | 240 | 33 | 27173435 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIFBP MARS1 UGGT1 GART WDR46 PSMD11 CMYA5 MAST2 LRRC47 GANAB SCFD1 CLUH SF3B2 PLXNA1 RASAL2 DNHD1 FLNB NCAPD3 ESYT1 PCLO NIPSNAP1 NOC3L NUP98 CCT2 PAICS LETM1 RDH11 TSR1 MDC1 DOCK7 TAF5L PEAK1 ATP2B1 KDM1A | 3.21e-10 | 1425 | 240 | 34 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MARS1 GART WDR46 PNO1 RIOK3 PSMD11 TRRAP MPRIP LRRC47 PTPN12 DST MIB1 SCFD1 SF3B2 RASAL2 FLNB FLNC ESYT1 NIPSNAP1 NOC3L CCT2 CREBBP PAICS ORC1 ARAP3 RDH11 PLEKHG3 FHOD1 MDC1 EXOC2 ATP2B1 KDM1A PHLDB2 | 3.45e-10 | 1353 | 240 | 33 | 29467282 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA8 SPIRE1 MAST2 PLXNB2 TRRAP MPRIP FANCA DST NLRC5 POLL MAFF DOCK6 PLXNA1 PLXNA3 FLNC CDC42BPA ZNF48 ESYT1 GTSE1 ARHGAP17 PPARA RALGAPA2 LDLR ORC1 ARAP3 CTDP1 PAXIP1 GGA1 TJP3 | 8.63e-10 | 1105 | 240 | 29 | 35748872 |
| Pubmed | HTRA1 IRF2BP1 HIPK1 SYTL2 PSMD11 MTMR10 ARID1B PTPN12 DST PIAS3 FLNB FLNC NELFCD GLRX3 PIAS2 PIAS1 CREBBP ARHGAP5 PAXIP1 KIF13A GGA1 | 1.17e-09 | 591 | 240 | 21 | 15231748 | |
| Pubmed | TET2 DSCR4 IFT172 HIPK1 CMYA5 MTMR10 FRMD4B MPRIP ZNF331 CCDC13 STX1A DST PIAS3 COG1 MIB1 SF3B2 RASAL2 FLNB CCT2 PIAS2 PIAS1 CREBBP PAICS SPTBN4 THAP4 ARHGAP5 TIAM1 SIPA1L1 PALS2 CADPS2 FUT8 | 1.62e-09 | 1285 | 240 | 31 | 35914814 | |
| Pubmed | MARS1 PPP1R12A UGGT1 SPIRE1 ACVR2A KLHL32 TTBK2 ARID1B RXFP2 POGLUT2 NMT1 FLNB AEN WDFY4 LDLR PAICS LETM1 ARHGAP5 RESF1 TSR1 INTS13 RASSF1 SIPA1L1 TET1 PEAK1 KIF13A TNS1 ATP2B1 | 2.45e-09 | 1084 | 240 | 28 | 11544199 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KIFBP MARS1 PPP1R12A UGGT1 GART NIPSNAP2 SPIRE1 RIOK3 PSMD11 PAK6 TIPRL CMYA5 MAST2 TRRAP MPRIP TTBK2 GANAB SF3B2 RASAL2 KLC1 NELFCD GLRX3 NIPSNAP1 NUP98 KLC2 ODC1 PAICS TIAM1 TSR1 MAP3K21 | 6.30e-09 | 1284 | 240 | 30 | 17353931 |
| Pubmed | PPP1R12A MAST2 MPRIP DST SF3B2 DNHD1 FLNB CDC42BPA TEX15 MDC1 CTDP1 PPIP5K1 KIF13A | 1.09e-08 | 234 | 240 | 13 | 36243803 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | PDE1B MARS1 PNO1 PAK6 MAST2 PLXNB2 BID ZNF331 DUS2 PIAS3 HERC3 SF3B2 KLC1 PLXNA3 GLRX3 NIPSNAP1 KLC2 APOA1 ODC1 CRABP1 SPTBN4 THAP4 RDH11 RASSF1 DOCK7 TAF5L TNS1 | 2.18e-08 | 1124 | 240 | 27 | 21900206 |
| Pubmed | 2.62e-08 | 130 | 240 | 10 | 12421765 | ||
| Pubmed | TET2 KIFBP VWA8 SPIRE1 FRMD4B LRRC47 ARID1B DST MIB1 SCFD1 DOCK6 NCAPD3 CDC42BPA SHOC2 TSR1 MDC1 TET1 KDM1A | 3.61e-08 | 529 | 240 | 18 | 14621295 | |
| Pubmed | DSCR4 MARS1 PPP1R12A GART PNO1 GANAB SF3B2 FLNC NCAPD3 CDC42BPA ZNF48 ESYT1 NOC3L ARHGAP17 CCT2 PAICS LETM1 MRPL39 CCDC124 TSR1 DOCK7 KDM1A | 5.73e-08 | 809 | 240 | 22 | 32129710 | |
| Pubmed | KIFBP IRF2BP1 VWA8 MARS1 UGGT1 PSMD11 LRRC47 CRACD GANAB DST COG1 SCFD1 VTI1B FLNB NCAPD3 GLRX3 ESYT1 GTSE1 NOC3L CCT2 PAICS LETM1 CCDC124 RDH11 PLEKHG3 SIPA1L1 MDC1 DOCK7 EXOC2 ATP2B1 | 7.97e-08 | 1440 | 240 | 30 | 30833792 | |
| Pubmed | Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. | 9.17e-08 | 54 | 240 | 7 | 23505323 | |
| Pubmed | KIFBP NIPSNAP2 TIPRL MAST2 ARID1B DST DOCK6 RASAL2 NIPSNAP1 KLC2 LETM1 RASSF1 SIPA1L1 DOCK7 MAP3K21 PHLDB2 | 1.04e-07 | 446 | 240 | 16 | 24255178 | |
| Pubmed | PPP1R12A UGGT1 GART PSMD11 MPRIP GANAB MIB1 KAZN DOCK6 ARAP2 CDC42BPA NIPSNAP1 NUP98 ARHGAP17 MSI1 PAICS ARHGAP5 ARAP3 TIAM1 PLEKHG3 DOCK7 PEAK1 KDM1A | 1.18e-07 | 916 | 240 | 23 | 32203420 | |
| Pubmed | ATP7A MARS1 GART TIPRL GANAB DST SF3B2 RASAL2 FLNB CDC42BPA GLRX3 ESYT1 CCT2 PAICS LETM1 CCDC124 DOCK7 PEAK1 MAP3K21 ATP2B1 | 1.29e-07 | 708 | 240 | 20 | 39231216 | |
| Pubmed | 1.51e-07 | 8 | 240 | 4 | 15661641 | ||
| Pubmed | UGGT1 GART WDR46 TRRAP LRRC47 GANAB DST CLUH SF3B2 FLNB FLNC NOC3L NUP98 CCT2 PAICS TSR1 MDC1 DOCK7 KDM1A | 1.71e-07 | 653 | 240 | 19 | 22586326 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.03e-07 | 123 | 240 | 9 | 26912792 | |
| Pubmed | HTRA1 MARS1 PPP1R12A NIPSNAP2 SPIRE1 MPRIP LRRC47 USP31 CRACD DST PLCL1 DNAH6 RASAL2 KLC1 FLNB FLNC PCLO NIPSNAP1 KLC2 CCT2 LETM1 SPTBN4 ARHGAP5 SIPA1L1 DOCK7 PEAK1 TNS1 ATP2B1 DNAH11 | 2.37e-07 | 1431 | 240 | 29 | 37142655 | |
| Pubmed | ATP7A PLXNB2 MPRIP USP31 GANAB DST SCFD1 RASAL2 ESYT1 RALGAPA2 ARHGAP5 PEAK1 PALS2 ATP2B1 PHLDB2 | 2.86e-07 | 421 | 240 | 15 | 36976175 | |
| Pubmed | PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. | 3.25e-07 | 3 | 240 | 3 | 12077349 | |
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 3.25e-07 | 3 | 240 | 3 | 11241833 | |
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 30861611 | ||
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 8806646 | ||
| Pubmed | HIPK1 PAK6 DST PIAS3 FLNC CDC42BPA NUP98 ARHGAP17 PIAS2 PIAS1 CREBBP USF3 FHOD1 MAP3K21 MAPK10 TNS1 | 3.28e-07 | 486 | 240 | 16 | 20936779 | |
| Pubmed | ATAD5 UGGT1 PTPN22 PSMD11 TIPRL MTMR10 USP31 ARID1B PTPN12 GANAB MIB1 CDC42BPA NOC3L NUP98 CCT2 SHOC2 LETM1 ARHGAP5 PPP2R5B TIAM1 TSR1 PEAK1 TNS1 ATP2B1 | 3.35e-07 | 1049 | 240 | 24 | 27880917 | |
| Pubmed | KIFBP ATP7A MRS2 VWA8 ATAD5 UGGT1 PLXNB2 MPRIP LRRC47 USP31 GANAB ERAP2 MIB1 SCFD1 TADA3 CLUH SF3B2 RASAL2 KLC1 CDC42BPA ESYT1 NIPSNAP1 NOC3L LETM1 MRPL39 TIAM1 TSR1 PEAK1 ATP2B1 | 5.21e-07 | 1487 | 240 | 29 | 33957083 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 6.67e-07 | 104 | 240 | 8 | 31240132 | |
| Pubmed | UGGT1 PSMD11 PLXNA1 CDC42BPG FLNB GTSE1 CREBBP RESF1 TSR1 TET1 TAF5L TNS1 KDM1A | 6.96e-07 | 335 | 240 | 13 | 15741177 | |
| Pubmed | 7.03e-07 | 11 | 240 | 4 | 24349473 | ||
| Pubmed | 7.88e-07 | 187 | 240 | 10 | 26460568 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IRF2BP1 MARS1 UGGT1 GART WDR46 PSMD11 PLXNB2 TRRAP GANAB DST SF3B2 FLNB FLNC GTSE1 NIPSNAP1 NUP98 CCT2 PLEKHG3 MDC1 DOCK7 ATP2B1 KDM1A PHLDB2 | 8.17e-07 | 1024 | 240 | 23 | 24711643 |
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 1.05e-06 | 12 | 240 | 4 | 24179230 | |
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.05e-06 | 12 | 240 | 4 | 21270798 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KIFBP MARS1 PPP1R12A UGGT1 GART PNO1 UBAP1 PSMD11 CMYA5 LRRC47 PTPN12 GANAB NMT1 CLUH KLC1 FLNB FLNC GLRX3 NUP98 KLC2 CCT2 PAICS CCDC124 TSR1 INTS13 ASMTL OGFOD1 KIF13A | 1.08e-06 | 1455 | 240 | 28 | 22863883 |
| Pubmed | IFT172 HIPK1 KLHL32 USP31 TRIL CRACD GANAB HERC3 PLXNA2 ARAP2 SIPA1L1 DOCK7 OGFOD1 PPIP5K1 | 1.09e-06 | 407 | 240 | 14 | 12693553 | |
| Pubmed | LYRM7 CTU2 MARS1 PPP1R12A UGGT1 GART PNO1 PSMD11 TIPRL PLXNB2 TRRAP PTPN12 GANAB DST POGLUT2 CLUH FLNB ESYT1 NIPSNAP1 CCT2 SHOC2 LDLR PAICS CCDC124 TSR1 MDC1 | 1.28e-06 | 1297 | 240 | 26 | 33545068 | |
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 1.29e-06 | 4 | 240 | 3 | 25518740 | |
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 11306810 | ||
| Pubmed | 1.29e-06 | 4 | 240 | 3 | 10725340 | ||
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 1.29e-06 | 4 | 240 | 3 | 8570614 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | IFT172 UGGT1 PSMD11 TIPRL MTMR10 PTPN12 GANAB PRMT9 CLUH SF3B2 FLNB FLNC NCAPD3 ESYT1 NUP98 APOA1 PAICS MRPL39 ARAP3 FUT8 ATP2B1 KDM1A | 1.31e-06 | 974 | 240 | 22 | 28675297 |
| Pubmed | 1.51e-06 | 13 | 240 | 4 | 10520995 | ||
| Pubmed | ATAD5 MARS1 PPP1R12A PNO1 SPIRE1 TRRAP MPRIP CRACD DST NMT1 TADA3 NCAPD3 CDC42BPA ZNF48 ESYT1 NOC3L PIAS1 ORC1 CCDC124 TSR1 PLEKHG3 INTS13 SIPA1L1 MDC1 TAF5L EXOC2 FUT8 KDM1A | 1.87e-06 | 1497 | 240 | 28 | 31527615 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MARS1 PPP1R12A UGGT1 GART PNO1 MPRIP LRRC47 DST NMT1 SF3B2 RASAL2 FLNB ESYT1 NOC3L NUP98 CCT2 PAICS MRPL39 TSR1 PLEKHG3 FHOD1 SIPA1L1 MDC1 DOCK7 PHLDB2 | 2.38e-06 | 1257 | 240 | 25 | 36526897 |
| Pubmed | TET2 IRF2BP1 MRS2 ATAD5 MARS1 ETV5 PSMD11 TRRAP MPRIP ARID1B GANAB DST GLI3 TADA3 CDC42BPA NOC3L NUP98 CCT2 PIAS2 PIAS1 CREBBP MRPL39 RESF1 MDC1 PAXIP1 TAF5L KDM1A | 2.40e-06 | 1429 | 240 | 27 | 35140242 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ATP7A PLXNB2 MTMR10 DST RASAL2 VTI1B CDC42BPA ESYT1 KLC2 TIAM1 DOCK7 PEAK1 ATP2B1 | 2.57e-06 | 377 | 240 | 13 | 38117590 |
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 25313870 | ||
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 15907835 | ||
| Pubmed | SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death. | 3.21e-06 | 5 | 240 | 3 | 28622293 | |
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 27703003 | ||
| Pubmed | HTRA1 VWA8 ATAD5 PPP1R12A MAST2 TRRAP ZNF469 ARID1B GLI3 TADA3 ARAP2 WDR72 MSI1 RALGAPA2 CREBBP LDLR RESF1 INTS13 CBY2 SIPA1L1 TAF5L KDM1A PHLDB2 | 3.45e-06 | 1116 | 240 | 23 | 31753913 | |
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 3.55e-06 | 34 | 240 | 5 | 19060911 | |
| Pubmed | HIPK1 RIOK3 PLXNB2 BID SGK3 ARID1B PLCL1 PLXNA1 PLXNA3 CDC42BPA PIAS1 CREBBP LDLR TAF5L MAPK10 ATP2B1 KDM1A DNAH11 | 3.79e-06 | 730 | 240 | 18 | 34857952 | |
| Pubmed | MYT1 ETV5 PIAS3 GLI3 NKX3-1 SF3B2 PLXNA1 PLXNA2 ZNF367 PLXNA3 ZNF48 PPARA PIAS2 PIAS1 THAP4 ZFP64 KDM8 EXOC2 ZNF99 | 4.01e-06 | 808 | 240 | 19 | 20412781 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | PPP1R12A UGGT1 DNHD1 FLNB NCAPD3 GTSE1 NUP98 PIAS2 PIAS1 CREBBP PAICS TSR1 ZFP64 MDC1 PAXIP1 OGFOD1 KDM1A | 4.87e-06 | 670 | 240 | 17 | 22990118 |
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 4.90e-06 | 17 | 240 | 4 | 17626059 | |
| Pubmed | 4.90e-06 | 17 | 240 | 4 | 11683995 | ||
| Pubmed | TRAF5 IRF2BP1 UGGT1 MIB1 CDC42BPG NOC3L CREBBP LETM1 CCDC124 PALS2 KDM1A | 4.98e-06 | 283 | 240 | 11 | 21903422 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | KIFBP UBAP1 MAST2 PLXNB2 TRRAP ARID1B USP42 KAZN PLXNA2 ZNF367 RASAL2 ARAP2 KLC2 ARHGAP17 PIAS2 ORC1 LACC1 RASSF1 TET1 OGFOD1 KDM8 MAPK10 XKRX CXCR2 | 6.21e-06 | 1242 | 240 | 24 | 30973865 |
| Pubmed | 6.26e-06 | 38 | 240 | 5 | 28680062 | ||
| Pubmed | Maternal high-fat diet alters Tet-mediated epigenetic regulation during heart development. | 6.39e-06 | 6 | 240 | 3 | 39262804 | |
| Pubmed | Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. | 6.39e-06 | 6 | 240 | 3 | 16029420 | |
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 6.39e-06 | 6 | 240 | 3 | 19480842 | |
| Pubmed | 6.77e-06 | 101 | 240 | 7 | 10997877 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 ARID1B NUP98 PIAS2 PIAS1 CREBBP RESF1 MDC1 TET1 PAXIP1 TAF5L KDM1A | 6.84e-06 | 351 | 240 | 12 | 38297188 |
| Pubmed | CTU2 PSMD11 MAST2 SGK3 USP42 MIB1 CLUH RASAL2 NCAPD3 CCT2 PIAS2 LDLR LETM1 THAP4 ZCCHC4 PALS2 DNAH11 | 7.02e-06 | 689 | 240 | 17 | 36543142 | |
| Pubmed | 7.92e-06 | 191 | 240 | 9 | 33762435 | ||
| Pubmed | Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. | 9.18e-06 | 41 | 240 | 5 | 18157088 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 1.11e-05 | 7 | 240 | 3 | 19655386 | |
| Pubmed | Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. | 1.11e-05 | 7 | 240 | 3 | 19217413 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 1.11e-05 | 7 | 240 | 3 | 19063725 | |
| Pubmed | 1.11e-05 | 7 | 240 | 3 | 9724754 | ||
| Pubmed | Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. | 1.11e-05 | 7 | 240 | 3 | 10520994 | |
| Pubmed | Endosomal SNARE proteins regulate CFTR activity and trafficking in epithelial cells. | 1.11e-05 | 7 | 240 | 3 | 18570918 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | CFTR PAK6 MTMR10 PLXNA1 PLXNA2 RASAL2 ARAP2 CDC42BPA ASAP3 RALGAPA2 PIEZO2 DOCK7 PEAK1 ATP2B1 PHLDB2 | 1.14e-05 | 569 | 240 | 15 | 30639242 |
| Pubmed | Class 5 transmembrane semaphorins control selective Mammalian retinal lamination and function. | 1.21e-05 | 21 | 240 | 4 | 21835343 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.24e-05 | 202 | 240 | 9 | 33005030 | |
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 16522640 | ||
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 1.77e-05 | 8 | 240 | 3 | 22368082 | |
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 8631787 | ||
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 11117529 | ||
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 38362011 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | VWA8 MARS1 UGGT1 GART PNO1 NIPSNAP2 LRRC47 GANAB NMT1 CLUH SF3B2 SPINK5 FLNB GLRX3 NIPSNAP1 CCT2 LDLR PAICS LETM1 MRPL39 CCDC124 TSR1 FHOD1 MDC1 EXOC2 | 1.80e-05 | 1415 | 240 | 25 | 28515276 |
| Pubmed | ATAD5 FANCA ARID1B PIAS3 TADA3 VTI1B AEN NCAPD3 CREBBP INTS13 MDC1 TAF5L ATP2B1 | 1.83e-05 | 453 | 240 | 13 | 29656893 | |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 2.11e-05 | 24 | 240 | 4 | 28893946 | |
| Pubmed | MARS1 PSMD11 DOCK6 CLUH ESYT1 PAICS RDH11 TSR1 SIPA1L1 DOCK7 ATP2B1 KDM1A | 2.44e-05 | 399 | 240 | 12 | 37536630 | |
| Pubmed | PPP1R12A UGGT1 NIPSNAP2 PLA2G4D DST COG1 FAM161A DLEC1 DNAH6 PLXNA2 PLXNA3 FLNB FLNC NELFCD PCLO NOC3L NUP98 CCT2 PPARA LETM1 SPTBN4 RDH11 CADPS2 IL1R1 ATP2B1 | 2.47e-05 | 1442 | 240 | 25 | 35575683 | |
| Pubmed | 2.64e-05 | 9 | 240 | 3 | 19909241 | ||
| Pubmed | PlexinA2 and semaphorin signaling during cardiac neural crest development. | 2.64e-05 | 9 | 240 | 3 | 11688557 | |
| Pubmed | A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation. | 2.64e-05 | 9 | 240 | 3 | 17533377 | |
| Pubmed | Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. | 2.64e-05 | 9 | 240 | 3 | 11162594 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.73e-05 | 125 | 240 | 7 | 32891193 | |
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | PSMD11 ASB10 TADA3 SF3B2 NELFCD TRIM39 PPARA RASSF1 DOCK7 ZNF333 KDM1A | 2.90e-05 | 342 | 240 | 11 | 23455924 |
| Pubmed | 2.99e-05 | 52 | 240 | 5 | 26633812 | ||
| Pubmed | TET2 IRF2BP1 MARS1 ETV5 PTPN22 PSMD11 TIPRL TRRAP ARID1B TADA3 NCAPD3 GLRX3 CCT2 PIAS1 CREBBP PAICS THAP4 RESF1 PAXIP1 TAF5L KDM1A | 3.00e-05 | 1103 | 240 | 21 | 34189442 | |
| Interaction | YWHAZ interactions | TET2 PDE1B PPP1R12A CFTR SPIRE1 PAK6 MAST2 MTMR10 MPRIP FSIP2 USP31 CRACD DST TESK2 SF3B2 RASAL2 KLC1 ARAP2 CDC42BPG NCAPD3 CDC42BPA NELFCD ESYT1 SH2D3C KLC2 PIAS1 TIAM1 PLEKHG3 FHOD1 SIPA1L1 MDC1 DOCK7 PRKD1 EXOC2 PEAK1 MAP3K21 TNS1 ATP2B1 PHLDB2 | 8.95e-08 | 1319 | 237 | 39 | int:YWHAZ |
| Interaction | YWHAH interactions | TET2 PPP1R12A CFTR SPIRE1 PAK6 MAST2 MTMR10 MPRIP USP31 DST TESK2 DOCK6 RASAL2 KLC1 ARAP2 CDC42BPG CDC42BPA NELFCD ESYT1 GTSE1 KLC2 ARHGAP17 PIAS2 CREBBP RESF1 TIAM1 PLEKHG3 SIPA1L1 TET1 DOCK7 PRKD1 PEAK1 MAP3K21 PHLDB2 | 2.53e-07 | 1102 | 237 | 34 | int:YWHAH |
| Interaction | YWHAG interactions | TET2 PPP1R12A CFTR SPIRE1 PAK6 MAST2 TRRAP MPRIP USP31 CRACD DST TESK2 RASAL2 KLC1 ARAP2 CDC42BPA NELFCD ESYT1 GTSE1 SH2D3C KLC2 ARHGAP17 CCT2 PIAS1 TIAM1 PLEKHG3 SIPA1L1 TET1 DOCK7 PPIP5K1 PRKD1 PEAK1 MAP3K21 KIF13A PHLDB2 | 1.52e-06 | 1248 | 237 | 35 | int:YWHAG |
| Interaction | C11orf52 interactions | ATP7A USP31 DST PLXNA1 RASAL2 ARAP2 CDC42BPA ESYT1 TIAM1 DOCK7 PEAK1 PALS2 MAP3K21 ATP2B1 PHLDB2 | 4.49e-06 | 311 | 237 | 15 | int:C11orf52 |
| Interaction | LURAP1L interactions | 4.82e-06 | 22 | 237 | 5 | int:LURAP1L | |
| Interaction | YWHAB interactions | TET2 PPP1R12A CFTR SPIRE1 PAK6 MAST2 TRRAP MPRIP BID USP31 DST TESK2 PRMT9 RASAL2 KLC1 ARAP2 NCAPD3 CDC42BPA ESYT1 KLC2 SHOC2 PAICS TIAM1 PLEKHG3 SIPA1L1 DOCK7 PEAK1 MAP3K21 PHLDB2 | 9.12e-06 | 1014 | 237 | 29 | int:YWHAB |
| Interaction | KCNA3 interactions | ATP7A ABCA13 MARS1 GART SYTL2 TIPRL MPRIP GANAB DST SF3B2 RASAL2 DNHD1 FLNB CDC42BPA GLRX3 ESYT1 CCT2 PAICS LETM1 ORC1 CCDC124 SIPA1L1 DOCK7 PEAK1 MAP3K21 ATP2B1 | 1.32e-05 | 871 | 237 | 26 | int:KCNA3 |
| Interaction | LYN interactions | ATP7A PLXNB2 USP31 DST NMT1 PLXNA1 RASAL2 ARAP2 CDC42BPA ESYT1 SH2D3C KLC2 CREBBP CSF2RA TIAM1 TSR1 DOCK7 PEAK1 PALS2 MAP3K21 IL1R1 ATP2B1 PHLDB2 | 1.48e-05 | 720 | 237 | 23 | int:LYN |
| Interaction | SNAI2 interactions | 1.57e-05 | 46 | 237 | 6 | int:SNAI2 | |
| Interaction | RHOB interactions | ATP7A PLXNB2 MPRIP USP31 GANAB SCFD1 PLXNA1 RASAL2 VTI1B CDC42BPA ESYT1 ARHGAP17 RALGAPA2 PIAS1 ARHGAP5 TIAM1 RDH11 PLEKHG3 SIPA1L1 DOCK7 EXOC2 PEAK1 MAP3K21 ATP2B1 PHLDB2 | 2.05e-05 | 840 | 237 | 25 | int:RHOB |
| Interaction | SFN interactions | TET2 PPP1R12A CFTR SPIRE1 MAST2 MPRIP USP31 DST RASAL2 KLC1 ARAP2 CDC42BPA KLC2 PIAS1 TIAM1 PLEKHG3 SIPA1L1 DOCK7 PEAK1 MAP3K21 KIF13A PHLDB2 | 2.46e-05 | 692 | 237 | 22 | int:SFN |
| Interaction | FGD5 interactions | PPP1R12A CFTR PSMD11 TRRAP MPRIP DST FLNB FLNC CCT2 PAICS DOCK7 | 3.58e-05 | 207 | 237 | 11 | int:FGD5 |
| Interaction | ANKRD34A interactions | 3.59e-05 | 53 | 237 | 6 | int:ANKRD34A | |
| Interaction | RND1 interactions | PLXNB2 GANAB DST CCNI PLXNA1 RASAL2 CDC42BPA ESYT1 ARHGAP5 FHOD1 PEAK1 ATP2B1 | 3.68e-05 | 246 | 237 | 12 | int:RND1 |
| Interaction | NADK interactions | 4.36e-05 | 80 | 237 | 7 | int:NADK | |
| Interaction | PHLDB2 interactions | 5.03e-05 | 143 | 237 | 9 | int:PHLDB2 | |
| Interaction | LIMA1 interactions | CFTR MTMR10 MPRIP DST TESK2 RASAL2 FLNB GTSE1 WDFY4 PIAS1 TIAM1 PLEKHG3 SIPA1L1 PAXIP1 MAP3K21 PHLDB2 | 5.20e-05 | 429 | 237 | 16 | int:LIMA1 |
| Interaction | SEMA5A interactions | 5.43e-05 | 7 | 237 | 3 | int:SEMA5A | |
| Interaction | RHOJ interactions | NIPSNAP2 PAK6 PLXNB2 GANAB PLXNA1 RASAL2 VTI1B CDC42BPA ESYT1 NIPSNAP1 NOC3L RALGAPA2 ARHGAP5 TIAM1 RDH11 PLEKHG3 FHOD1 PEAK1 ATP2B1 PHLDB2 | 6.34e-05 | 633 | 237 | 20 | int:RHOJ |
| Interaction | RHOQ interactions | NIPSNAP2 ACVR2A PLXNB2 GANAB DST RASAL2 VTI1B CDC42BPG CDC42BPA ESYT1 RALGAPA2 ARHGAP5 TIAM1 PLEKHG3 PEAK1 ATP2B1 | 7.39e-05 | 442 | 237 | 16 | int:RHOQ |
| Interaction | YWHAE interactions | TET2 PPP1R12A CFTR SPIRE1 PAK6 MAST2 FRMD4B MPRIP USP31 CRACD DST TESK2 SF3B2 RASAL2 KLC1 ARAP2 CDC42BPA ESYT1 GTSE1 KLC2 SHOC2 TIAM1 PLEKHG3 SIPA1L1 TET1 DOCK7 OGFOD1 PRKD1 PEAK1 MAP3K21 PHLDB2 | 7.49e-05 | 1256 | 237 | 31 | int:YWHAE |
| Interaction | CGN interactions | CFTR MTMR10 TESK2 RASAL2 TIAM1 SIPA1L1 MAP3K21 ATP2B1 PHLDB2 | 8.07e-05 | 152 | 237 | 9 | int:CGN |
| Interaction | H2BC9 interactions | LYRM7 ABCA13 TRRAP FSIP2 ZNF469 DST DNAH6 PCLO NUP98 LAMA2 TEX15 USF3 ARAP3 CCDC124 MDC1 KDM1A | 8.21e-05 | 446 | 237 | 16 | int:H2BC9 |
| Interaction | MYH9 interactions | TET2 MYOM1 PPP1R12A CFTR PSMD11 TRRAP MPRIP DST DNAH6 KLC1 FLNB GTSE1 WDFY4 PIAS1 CREBBP LDLR LETM1 CCDC124 TSR1 PLEKHG3 DOCK7 KDM1A | 8.77e-05 | 754 | 237 | 22 | int:MYH9 |
| Interaction | RND3 interactions | CFTR PLXNB2 MPRIP GANAB DST RASAL2 CDC42BPA ESYT1 ARHGAP5 FHOD1 PEAK1 ATP2B1 | 9.99e-05 | 273 | 237 | 12 | int:RND3 |
| Interaction | LRFN1 interactions | 1.11e-04 | 124 | 237 | 8 | int:LRFN1 | |
| Interaction | INPP5E interactions | 1.15e-04 | 65 | 237 | 6 | int:INPP5E | |
| Interaction | TOP3B interactions | VWA8 SPIRE1 MAST2 PLXNB2 TRRAP MPRIP FANCA DST MIB1 NLRC5 POLL MAFF DOCK6 NMT1 PLXNA1 PLXNA3 FLNC CDC42BPA ZNF48 GLRX3 ESYT1 GTSE1 NIPSNAP1 ARHGAP17 PPARA RALGAPA2 LDLR ORC1 ARAP3 MDC1 CTDP1 PAXIP1 GGA1 TJP3 | 1.17e-04 | 1470 | 237 | 34 | int:TOP3B |
| Interaction | WARS1 interactions | GART NIPSNAP2 TRRAP PTPN12 GANAB SF3B2 FLNB FLNC ARHGAP17 PAICS | 1.18e-04 | 197 | 237 | 10 | int:WARS1 |
| Interaction | PLS3 interactions | MARS1 PPP1R12A CFTR GART PSMD11 GANAB SF3B2 FLNB FLNC WDFY4 PIAS1 | 1.21e-04 | 237 | 237 | 11 | int:PLS3 |
| Interaction | YWHAQ interactions | TET2 PPP1R12A CFTR SPIRE1 CHAT PSMD11 PAK6 MAST2 MPRIP USP31 DST USP42 TESK2 RASAL2 KLC1 ARAP2 CDC42BPA GTSE1 KLC2 TIAM1 PLEKHG3 SIPA1L1 TET1 DOCK7 PRKD1 PEAK1 MAP3K21 PHLDB2 | 1.34e-04 | 1118 | 237 | 28 | int:YWHAQ |
| Interaction | FAM110B interactions | 1.36e-04 | 67 | 237 | 6 | int:FAM110B | |
| Interaction | RAC1 interactions | ATP7A PAK6 PLXNB2 MTMR10 DST PIAS3 SCFD1 DOCK6 PLXNA1 RASAL2 ARAP2 VTI1B CDC42BPG FLNB NCAPD3 CDC42BPA ESYT1 ARHGAP17 ARHGAP5 TIAM1 LACC1 PLEKHG3 FHOD1 DOCK7 PEAK1 ATP2B1 PHLDB2 | 1.42e-04 | 1063 | 237 | 27 | int:RAC1 |
| Interaction | FAM53C interactions | 1.48e-04 | 68 | 237 | 6 | int:FAM53C | |
| Interaction | TXLNB interactions | 1.49e-04 | 97 | 237 | 7 | int:TXLNB | |
| Interaction | DENND1A interactions | 1.92e-04 | 101 | 237 | 7 | int:DENND1A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.31e-04 | 147 | 240 | 6 | chr15q15 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | MPRIP RASAL2 ARAP2 CDC42BPG ASAP3 SPTBN4 ARAP3 TIAM1 PLEKHG3 PRKD1 CADPS2 PHLDB2 | 3.50e-07 | 206 | 162 | 12 | 682 |
| GeneFamily | Plexins | 7.56e-07 | 9 | 162 | 4 | 683 | |
| GeneFamily | Zinc fingers MIZ-type | 2.41e-05 | 7 | 162 | 3 | 85 | |
| GeneFamily | PDZ domain containing | 4.44e-04 | 152 | 162 | 7 | 1220 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | ATAD5 STK32B GART PNO1 PGLYRP2 PSMD11 SGK3 FANCA USP31 DUS2 FAM161A MIB1 NMT1 ZNF367 AEN GLRX3 GTSE1 NOC3L ARHGAP17 CCT2 PIAS2 PAICS MRPL39 ORC1 TSR1 SIPA1L1 MDC1 PRKD1 PALS2 TNS1 | 2.80e-06 | 1290 | 240 | 30 | M80 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PPP1R12A TIPRL MAST2 TRRAP ZNF804A PTPN12 DST KAZN KLC1 ARAP2 FLNB CDC42BPA NUP98 SHOC2 CREBBP LDLR TIAM1 SIPA1L1 PALS2 IL1R1 FUT8 ATP2B1 | 1.44e-05 | 856 | 240 | 22 | M4500 |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | PDE1B MPRIP USP31 TRIL ARID1B GLI3 DOCK6 ZNF367 RASAL2 PLXNA3 AEN ARHGAP17 TEX15 CRABP1 PIAS2 MAP3K21 KDM1A | 1.92e-05 | 563 | 240 | 17 | M15103 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | GART CHAD CHAT MAST2 DUS2 DLEC1 POGLUT2 DOCK6 PLXNA1 PLXNA2 SPINK5 FLNC ASAP3 NUP98 LAMA2 THTPA TEX15 TRIM23 SLC12A3 SPACA1 GGA1 TNS1 | 3.58e-05 | 909 | 240 | 22 | M41018 |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN | 3.59e-05 | 175 | 240 | 9 | M34029 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | MBOAT1 UBAP1 PTPN12 ARAP2 ODC1 PIAS1 CREBBP USF3 FHOD1 PEAK1 PHLDB2 | 3.61e-05 | 265 | 240 | 11 | M1684 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | MBOAT1 UBAP1 PTPN12 ARAP2 ODC1 PIAS1 CREBBP USF3 FHOD1 PEAK1 PHLDB2 | 4.58e-05 | 272 | 240 | 11 | MM1027 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP | 5.16e-05 | 228 | 240 | 10 | M2151 | |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_DN | 5.31e-05 | 184 | 240 | 9 | M6739 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | MRS2 PDGFRL GART WDR46 PNO1 RIOK3 TRRAP FANCA VTI1B GTSE1 CCT2 ODC1 THAP4 TSR1 PAXIP1 ATP2B1 KDM1A | 5.45e-05 | 612 | 240 | 17 | M4772 |
| Coexpression | NAGY_PCAF_COMPONENTS_HUMAN | 6.11e-05 | 9 | 240 | 3 | M5039 | |
| Coexpression | GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN | 8.30e-05 | 195 | 240 | 9 | M5445 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 8.97e-05 | 197 | 240 | 9 | M7921 | |
| Coexpression | GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN | 9.33e-05 | 198 | 240 | 9 | M7265 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 9.52e-05 | 155 | 240 | 8 | M39246 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 9.69e-05 | 199 | 240 | 9 | M7254 | |
| Coexpression | GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP | 9.69e-05 | 199 | 240 | 9 | M6547 | |
| Coexpression | GSE3982_MAST_CELL_VS_DC_UP | 9.69e-05 | 199 | 240 | 9 | M5426 | |
| Coexpression | GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP | 1.01e-04 | 200 | 240 | 9 | M331 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 1.01e-04 | 200 | 240 | 9 | M9909 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | PPP1R12A FRMD4B MPRIP CLIC5 HERC3 SCFD1 NIPSNAP1 NUP98 IL1R1 | 1.01e-04 | 200 | 240 | 9 | M8427 |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP | 1.01e-04 | 200 | 240 | 9 | M9840 | |
| Coexpression | MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN | 1.31e-04 | 207 | 240 | 9 | M38977 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.36e-04 | 208 | 240 | 9 | M39233 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.56e-04 | 212 | 240 | 9 | M39221 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATP7A MYOM1 ATAD5 ETV5 SPIRE1 KLHL32 PLCL1 PLXNA1 WDFY4 SPACA1 FHOD1 SIPA1L1 | 9.61e-11 | 163 | 240 | 12 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATP7A MYOM1 ATAD5 ETV5 SPIRE1 KLHL32 PLCL1 PLXNA1 WDFY4 SPACA1 FHOD1 SIPA1L1 | 9.61e-11 | 163 | 240 | 12 | fd243ca223079033be480a24817a399f281fa4d4 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | MYOM1 CMYA5 MAST2 ZNF331 CLIC5 PLCL1 FLNC LAMA2 FHOD3 PHLDB2 | 8.88e-08 | 190 | 240 | 10 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | STK32B CMYA5 PLPPR1 KAZN PLCL1 WDR72 PCLO FHOD3 PPARA MAPK10 | 1.03e-07 | 193 | 240 | 10 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-07 | 155 | 240 | 9 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.41e-07 | 130 | 240 | 8 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-07 | 189 | 240 | 9 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 9.15e-07 | 189 | 240 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | STK32B MTMR10 ARID1B KAZN PLCL1 CDC42BPA PRKD1 CADPS2 MAPK10 | 9.15e-07 | 189 | 240 | 9 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 9.15e-07 | 189 | 240 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-07 | 190 | 240 | 9 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 193 | 240 | 9 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 193 | 240 | 9 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-06 | 194 | 240 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-06 | 195 | 240 | 9 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 195 | 240 | 9 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.29e-06 | 197 | 240 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.46e-06 | 200 | 240 | 9 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 104 | 240 | 7 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 157 | 240 | 8 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-06 | 166 | 240 | 8 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.89e-06 | 169 | 240 | 8 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-06 | 169 | 240 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-06 | 172 | 240 | 8 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 178 | 240 | 8 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-06 | 181 | 240 | 8 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.71e-06 | 182 | 240 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.99e-06 | 183 | 240 | 8 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 185 | 240 | 8 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-06 | 186 | 240 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.19e-06 | 187 | 240 | 8 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-06 | 187 | 240 | 8 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 8.51e-06 | 188 | 240 | 8 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-06 | 189 | 240 | 8 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.85e-06 | 189 | 240 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.19e-06 | 190 | 240 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 190 | 240 | 8 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-06 | 191 | 240 | 8 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-06 | 192 | 240 | 8 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 9.92e-06 | 192 | 240 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.03e-05 | 193 | 240 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.03e-05 | 193 | 240 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 193 | 240 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 193 | 240 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.03e-05 | 193 | 240 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-05 | 193 | 240 | 8 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 194 | 240 | 8 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 194 | 240 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 194 | 240 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.11e-05 | 195 | 240 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 195 | 240 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 196 | 240 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.15e-05 | 196 | 240 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 197 | 240 | 8 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 197 | 240 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 197 | 240 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.20e-05 | 197 | 240 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 197 | 240 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 198 | 240 | 8 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 198 | 240 | 8 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.14e-05 | 155 | 240 | 7 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.23e-05 | 156 | 240 | 7 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-05 | 156 | 240 | 7 | c11ca6b1b5029c15aab91273cece70a487287839 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.23e-05 | 156 | 240 | 7 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 2.33e-05 | 157 | 240 | 7 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 159 | 240 | 7 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-05 | 163 | 240 | 7 | 2dbdcbc4c187aad3db837d191cc78662a75dd0b5 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.33e-05 | 166 | 240 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 167 | 240 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-05 | 168 | 240 | 7 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 3.73e-05 | 169 | 240 | 7 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-05 | 169 | 240 | 7 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.73e-05 | 169 | 240 | 7 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.87e-05 | 170 | 240 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-05 | 170 | 240 | 7 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.87e-05 | 170 | 240 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-05 | 171 | 240 | 7 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.65e-05 | 175 | 240 | 7 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.65e-05 | 175 | 240 | 7 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 176 | 240 | 7 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 176 | 240 | 7 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-05 | 178 | 240 | 7 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-05 | 178 | 240 | 7 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.22e-05 | 122 | 240 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 179 | 240 | 7 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 179 | 240 | 7 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 180 | 240 | 7 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 180 | 240 | 7 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 180 | 240 | 7 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 5.56e-05 | 180 | 240 | 7 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.76e-05 | 181 | 240 | 7 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.76e-05 | 181 | 240 | 7 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 5.76e-05 | 181 | 240 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 182 | 240 | 7 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-05 | 182 | 240 | 7 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.96e-05 | 182 | 240 | 7 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| Disease | free cholesterol in small HDL measurement | 7.87e-06 | 35 | 233 | 5 | EFO_0022270 | |
| Disease | ascending aortic diameter | 1.29e-04 | 140 | 233 | 7 | EFO_0021787 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.31e-04 | 13 | 233 | 3 | DOID:2531 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TET2 PDGFRL ABCA13 CFTR PAK6 ZNF804A LRRC47 GLI3 RASAL2 FLNC ASAP3 ODC1 ARAP3 TIAM1 INTS13 PRKD1 | 1.61e-04 | 702 | 233 | 16 | C0009402 |
| Disease | total lipids in small HDL measurement | 1.64e-04 | 35 | 233 | 4 | EFO_0022311 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | major depressive disorder (biomarker_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:1470 (biomarker_via_orthology) | |
| Disease | phospholipids in small HDL measurement | 2.27e-04 | 38 | 233 | 4 | EFO_0022296 | |
| Disease | glucagon measurement | 2.32e-04 | 154 | 233 | 7 | EFO_0008463 | |
| Disease | Schizophrenia | ABCA13 CHAT CMYA5 TRRAP ZNF804A BID CFAP65 STX1A PLXNA2 LAMA2 APOA4 ETNPPL PPARA CSF2RA TET1 PAH CADPS2 FUT8 | 2.49e-04 | 883 | 233 | 18 | C0036341 |
| Disease | Schizoaffective disorder-bipolar type | 2.52e-04 | 16 | 233 | 3 | EFO_0009965 | |
| Disease | uric acid measurement | TET2 STK32B SYTL2 ETV5 ACVR2A FANCA DUS2 WDR72 CDC42BPG CDC42BPA ARHGAP17 SLCO1B1 PPP2R5B MAPK10 | 3.84e-04 | 610 | 233 | 14 | EFO_0004761 |
| Disease | Chagas cardiomyopathy | 4.01e-04 | 44 | 233 | 4 | EFO_0005529 | |
| Disease | lipoprotein measurement, phospholipid measurement | 5.77e-04 | 85 | 233 | 5 | EFO_0004639, EFO_0004732 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 5.82e-04 | 21 | 233 | 3 | OBA_2045156 | |
| Disease | pulmonary alveolar proteinosis (implicated_via_orthology) | 6.11e-04 | 5 | 233 | 2 | DOID:12120 (implicated_via_orthology) | |
| Disease | polyunsaturated fatty acid measurement | 6.25e-04 | 131 | 233 | 6 | EFO_0010733 | |
| Disease | Alzheimer's disease (is_implicated_in) | 6.50e-04 | 132 | 233 | 6 | DOID:10652 (is_implicated_in) | |
| Disease | lipid measurement, lipoprotein measurement | 7.49e-04 | 90 | 233 | 5 | EFO_0004529, EFO_0004732 | |
| Disease | Renal glomerular disease | 7.66e-04 | 23 | 233 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 7.66e-04 | 23 | 233 | 3 | C4521256 | |
| Disease | HMG CoA reductase inhibitor use measurement | 7.93e-04 | 189 | 233 | 7 | EFO_0009932 | |
| Disease | interleukin 1 receptor antagonist measurement | 8.19e-04 | 53 | 233 | 4 | EFO_0004754 | |
| Disease | Dyslipidemias | 8.70e-04 | 24 | 233 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 8.70e-04 | 24 | 233 | 3 | C0598784 | |
| Disease | Congenital defect of skull and scalp | 9.12e-04 | 6 | 233 | 2 | C2931779 | |
| Disease | X-11423--O-sulfo-L-tyrosine measurement | 9.12e-04 | 6 | 233 | 2 | EFO_0021231 | |
| Disease | Adams Oliver syndrome | 9.12e-04 | 6 | 233 | 2 | C0265268 | |
| Disease | demyelinating disease (implicated_via_orthology) | 9.12e-04 | 6 | 233 | 2 | DOID:3213 (implicated_via_orthology) | |
| Disease | Adams-Oliver syndrome 1 | 9.12e-04 | 6 | 233 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 9.12e-04 | 6 | 233 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 9.54e-04 | 315 | 233 | 9 | EFO_0004612, EFO_0008591 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.09e-03 | 321 | 233 | 9 | EFO_0004612, EFO_0004639 | |
| Disease | photoreceptor cell layer thickness measurement | 1.18e-03 | 148 | 233 | 6 | EFO_0803370 | |
| Disease | Generalized seizures | 1.26e-03 | 101 | 233 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.26e-03 | 101 | 233 | 5 | C0234535 | |
| Disease | neurotic disorder | 1.26e-03 | 101 | 233 | 5 | EFO_0004257 | |
| Disease | Non-epileptic convulsion | 1.26e-03 | 101 | 233 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.26e-03 | 101 | 233 | 5 | C0751123 | |
| Disease | Single Seizure | 1.26e-03 | 101 | 233 | 5 | C0751110 | |
| Disease | Visual seizure | 1.26e-03 | 101 | 233 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.26e-03 | 101 | 233 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 1.26e-03 | 101 | 233 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.26e-03 | 101 | 233 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.26e-03 | 101 | 233 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.26e-03 | 101 | 233 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.26e-03 | 101 | 233 | 5 | C0422852 | |
| Disease | Convulsive Seizures | 1.26e-03 | 101 | 233 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.26e-03 | 101 | 233 | 5 | C0751496 | |
| Disease | Complex partial seizures | 1.26e-03 | 101 | 233 | 5 | C0149958 | |
| Disease | Nonepileptic Seizures | 1.26e-03 | 101 | 233 | 5 | C3495874 | |
| Disease | Generalized Absence Seizures | 1.26e-03 | 101 | 233 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 1.26e-03 | 101 | 233 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 1.26e-03 | 101 | 233 | 5 | C4317109 | |
| Disease | Alzheimer's disease 1 (implicated_via_orthology) | 1.27e-03 | 7 | 233 | 2 | DOID:0080348 (implicated_via_orthology) | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 1.27e-03 | 7 | 233 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | total lipids in VLDL measurement | 1.31e-03 | 60 | 233 | 4 | EFO_0022314 | |
| Disease | Absence Seizures | 1.32e-03 | 102 | 233 | 5 | C4316903 | |
| Disease | Convulsions | 1.32e-03 | 102 | 233 | 5 | C4048158 | |
| Disease | Tonic Seizures | 1.32e-03 | 102 | 233 | 5 | C0270844 | |
| Disease | free cholesterol in very large VLDL measurement | 1.39e-03 | 61 | 233 | 4 | EFO_0022274 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.40e-03 | 153 | 233 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | Tonic - clonic seizures | 1.43e-03 | 104 | 233 | 5 | C0494475 | |
| Disease | Seizures, Focal | 1.43e-03 | 104 | 233 | 5 | C0751495 | |
| Disease | Myoclonic Seizures | 1.43e-03 | 104 | 233 | 5 | C4317123 | |
| Disease | triglycerides in medium LDL measurement | 1.48e-03 | 62 | 233 | 4 | EFO_0022322 | |
| Disease | sphingomyelin measurement | 1.73e-03 | 278 | 233 | 8 | EFO_0010118 | |
| Disease | cholesterol in large VLDL measurement | 1.76e-03 | 65 | 233 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.76e-03 | 65 | 233 | 4 | EFO_0022230 | |
| Disease | Seizures | 1.81e-03 | 218 | 233 | 7 | C0036572 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.86e-03 | 31 | 233 | 3 | EFO_0022249 | |
| Disease | free cholesterol in large VLDL measurement | 2.08e-03 | 68 | 233 | 4 | EFO_0022265 | |
| Disease | Prostatic Cancer, Castration-Resistant | 2.15e-03 | 9 | 233 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 2.15e-03 | 9 | 233 | 2 | C3658267 | |
| Disease | plexin-B2 measurement | 2.15e-03 | 9 | 233 | 2 | EFO_0021867 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 2.19e-03 | 69 | 233 | 4 | EFO_0022341 | |
| Disease | antihyperlipidemic drug use measurement | 2.23e-03 | 115 | 233 | 5 | EFO_0803367 | |
| Disease | phospholipids:total lipids ratio | 2.27e-03 | 227 | 233 | 7 | EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.30e-03 | 291 | 233 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | waist circumference | 2.31e-03 | 429 | 233 | 10 | EFO_0004342 | |
| Disease | cortical surface area measurement | TET2 MYT1 ACVR2A MAST2 PLXNB2 FRMD4B MPRIP ZNF469 ARID1B GLI3 PLCL1 PLXNA2 FLNB NCAPD3 LAMA2 MDC1 PRKD1 EXOC2 TNS1 KDM1A DNAH11 | 2.39e-03 | 1345 | 233 | 21 | EFO_0010736 |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 2.43e-03 | 71 | 233 | 4 | EFO_0022259 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.68e-03 | 10 | 233 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | head circumference | 2.68e-03 | 10 | 233 | 2 | EFO_0005114 | |
| Disease | octadecanedioate measurement | 2.68e-03 | 10 | 233 | 2 | EFO_0021056 | |
| Disease | blood nickel measurement | 2.69e-03 | 120 | 233 | 5 | EFO_0007583 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 2.69e-03 | 120 | 233 | 5 | EFO_0004611, EFO_0004639 | |
| Disease | S-6-hydroxywarfarin measurement | 2.75e-03 | 368 | 233 | 9 | EFO_0803326 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.83e-03 | 74 | 233 | 4 | EFO_0022280 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.83e-03 | 301 | 233 | 8 | DOID:684 (is_marker_for) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.95e-03 | 303 | 233 | 8 | EFO_0004612, EFO_0020945 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.26e-03 | 11 | 233 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Cystic Fibrosis | 3.26e-03 | 11 | 233 | 2 | C0010674 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.31e-03 | 243 | 233 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | esterified cholesterol measurement | 3.54e-03 | 128 | 233 | 5 | EFO_0008589 | |
| Disease | Renal Cell Carcinoma | 3.54e-03 | 128 | 233 | 5 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.54e-03 | 128 | 233 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.54e-03 | 128 | 233 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.54e-03 | 128 | 233 | 5 | C1266044 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSVPHTKSLESRIKE | 306 | O75528 | |
| KDVPASELHELLSRK | 66 | Q15173 | |
| SRLSEEELPAILKHK | 136 | Q6ZT62 | |
| LLKSTTDPLIHKIAR | 331 | Q6PI77 | |
| SLTIPNAKDVLRKRH | 16 | Q8WTP8 | |
| SSRHQTLPERKKLSE | 731 | Q96QE3 | |
| DPEKKLFSHRILSRD | 261 | Q9Y5B0 | |
| RAEDLPLRKGTKHLS | 806 | Q9BSJ8 | |
| LVDTLPSIKHKDALV | 196 | Q9Y2D0 | |
| PHDLTKLLIAEVKSR | 421 | Q8TDY4 | |
| SAADTPDKKEHLVLV | 861 | Q8WWN8 | |
| VLSLAPELKHDVKET | 51 | Q6P2P2 | |
| LSKAKILLLDEPSAH | 1361 | P13569 | |
| KKATLHAVDVTLDPD | 296 | Q13410 | |
| RLVEKPSRGSEEHLK | 26 | Q8WXI3 | |
| PAISHRDIKSKNVLL | 316 | P27037 | |
| SLLDRFLATVKAHPK | 71 | Q14094 | |
| PDAASKHKQLSELLR | 61 | Q92793 | |
| KSLGEKAPLRLHSEK | 636 | Q9NR61 | |
| KKIAATVRHEVSPLH | 1226 | Q96DT5 | |
| AISRASEESHVLKPL | 2481 | Q86UQ4 | |
| LTEIKRKQTSRLDPH | 901 | A6QL63 | |
| ERDHLTKVYSKLPES | 366 | Q9UGM1 | |
| KSHRNIKLLEDEPRS | 1981 | Q8NFD5 | |
| PLHISELLESFKKDA | 1156 | Q8WZ64 | |
| KATLDSDHKLPSRVI | 1666 | Q8WZ64 | |
| TEHLSTLSEKAKPAL | 221 | P02647 | |
| SLLDLHLRLKEEKAP | 2226 | Q96M86 | |
| ASASPLHREEKILPK | 36 | P56555 | |
| SKLRVVEELKLSHNP | 216 | O15335 | |
| TTVDLKRKPADLHNL | 211 | Q9NZA1 | |
| KLRVLARSSPTDKHT | 761 | P20020 | |
| LVKDHLKRTPATAEA | 371 | Q8TBG4 | |
| TVKPEAELAIHILKS | 1231 | Q04656 | |
| IHADASSKVLAKIPR | 16 | Q9UGP5 | |
| VRKVDPRKDAHSNLL | 51 | O75323 | |
| PKDAVKHLHVLSRTR | 211 | Q9NS23 | |
| KVAVAAASKPHVEIR | 31 | P29762 | |
| ISAKEELVLHPAKSS | 361 | Q9Y2R2 | |
| SVKLRSPKSELHQDR | 676 | Q9Y2R2 | |
| RSKKELSPVLTSEVH | 221 | Q9NVM9 | |
| KVELSRKHQEALHAP | 426 | Q6DT37 | |
| QASLRPHADELKAKI | 176 | P06727 | |
| EESLKRAHVSPLFKA | 961 | Q6ZW49 | |
| SDDLKKRREPHISTL | 101 | Q8N543 | |
| ESTRRHKKATDSLPV | 236 | Q8NFK1 | |
| ESPFKVHLEKLSLRQ | 1191 | P52948 | |
| LKNSHKVSPVLRDFL | 621 | Q9NQU5 | |
| LSSEKGRLPEHITKF | 671 | Q15139 | |
| ILTPEKEHFIRAETK | 121 | Q6WCQ1 | |
| ERASLIKKEIHGSLP | 81 | P10071 | |
| SLATLTKDVPKRHSL | 246 | Q674X7 | |
| LKIKRELSENTPHLS | 11 | Q9ULX9 | |
| KIRALVRAHSEKDQP | 476 | Q14676 | |
| IHRDLKPSNIVVKSD | 186 | P53779 | |
| LNPRKLIEVKFSHLS | 301 | P30419 | |
| SLLIKHFDPRKADSI | 121 | Q8IXH7 | |
| NHLKRSEKESPLFLL | 451 | Q9NXD2 | |
| EDLNLRLKKLTHAAP | 131 | O76003 | |
| IDADKRITPLKTLNH | 501 | Q86Z02 | |
| LERAKLQEKPSHVRA | 961 | Q9NQ38 | |
| KSHPISAKLDVLESL | 4871 | Q03001 | |
| LRELSIHSDIDLKKP | 716 | Q15034 | |
| LRELSPDIAHLASLK | 191 | Q8N1G4 | |
| PDDKVHKLLSRVAES | 531 | O95671 | |
| SREEPLQLKLDTHKS | 871 | Q6ZU64 | |
| LASASRKDHVLDIPT | 416 | Q9H9K5 | |
| ALRALLPHSKEDLKL | 21 | Q8N371 | |
| KHIPESKLTSLAAAL | 661 | O95202 | |
| EIVARLLSKIFSPKH | 4311 | Q5CZC0 | |
| RVKVDPSHDASKVKA | 836 | O75369 | |
| IFPHARIKITRDSKD | 4491 | Q9Y6V0 | |
| ESKNHPKLLLRRTES | 1421 | Q9UIW2 | |
| RLDDLFILVEPSHKK | 141 | O75051 | |
| ESKNHPKLLLRRTES | 1396 | P51805 | |
| TEHKLSRDSPSNKLL | 1726 | O15031 | |
| RRSHLLVKPVKAALD | 56 | O15428 | |
| DKLLETPSTLHDQKR | 341 | Q96KP1 | |
| IDKPKALSLLLHAAD | 356 | Q01064 | |
| SIKVPETHKAVLALR | 406 | Q9H792 | |
| ELEQKVPAAKTRHTA | 36 | Q96PD5 | |
| IHGLISKDSLPKDSR | 331 | P25025 | |
| IKVLPAHDASKVRAS | 1531 | Q14315 | |
| DALVDPKHSSVDRSK | 216 | Q9HD23 | |
| PKHSSVDRSKLHILL | 221 | Q9HD23 | |
| LPKLKESRSHESLLS | 81 | Q9UJF2 | |
| DEKNLSSIKVIVPRH | 96 | Q8IV20 | |
| LLKSSHPEDLRAANK | 181 | Q9UJY5 | |
| KDLAHEATKLATGPR | 1946 | P24043 | |
| TKIKRELHSPSSELS | 86 | P41161 | |
| HLSPTAAEAKEKARA | 301 | Q15599 | |
| TDVKPLKGDHLSRAI | 166 | Q9NRX1 | |
| PSDSDDSLTKKLRHL | 1726 | Q2PPJ7 | |
| FNPSDHDLVLIRLKK | 491 | Q04756 | |
| SRHELDSKTIDPKVA | 81 | O43347 | |
| RTKIPAEKESHRDVL | 246 | Q9NYZ3 | |
| NLTHIESRPSRLKKD | 61 | P00439 | |
| PRVKKVDLRSLHHAT | 1191 | Q86WI3 | |
| TDHNTLKLVPRKDLL | 76 | Q5U5X0 | |
| ELSRLALKHKTPEVH | 1131 | Q9UG01 | |
| ALAIREKTLGKDHPA | 266 | Q9H0B6 | |
| PLHDAISKKRDDILA | 566 | Q86YT6 | |
| DDKKASPEHRIILRT | 306 | Q13415 | |
| NPIVKSLAKAHERLE | 31 | Q9NZW5 | |
| SPLLHKDSASLEVVK | 216 | Q8NA61 | |
| PLSKVHLETAEKLDR | 381 | Q8IYK2 | |
| ATLRLPRKAAAKSEH | 871 | Q9Y2L6 | |
| HLTDKLKRTPSADVI | 466 | Q9C0G6 | |
| PSDKIKKFLTESHDR | 356 | Q92743 | |
| VRFPSKLSSDLKHLL | 256 | P22612 | |
| PRDITAEFLVKSKHR | 471 | O60341 | |
| LPEQHKRKTLLSTDH | 1866 | Q96HP0 | |
| LIPIHEANRDAKKLS | 1801 | Q96N67 | |
| RSKPDSRIEKVTDHL | 831 | Q8WTW3 | |
| VHLAKRLVSDPALEK | 296 | Q96MS3 | |
| PKKSFSHVAELLADR | 1411 | O15360 | |
| HSLSEVKLKTADEPR | 2236 | Q8N3K9 | |
| AGSLHKSTALPEEKR | 1141 | Q6ZU35 | |
| HLEKIRLEPGKASAS | 601 | Q8IYE1 | |
| KLEPIKVDTSRLEHL | 921 | Q2V2M9 | |
| ASPARKLEEILHLAE | 831 | Q86UW7 | |
| AKKVASHTPSLLRDV | 156 | P55957 | |
| SLIEDSQALHKRPKL | 206 | Q8IV03 | |
| DLSAEQHRLAIKVKP | 166 | Q6ZNC8 | |
| RKHSLDLPHSELKKE | 1426 | Q6P0Q8 | |
| HRHILKSKTDTLDLP | 601 | Q6P179 | |
| IRLSHSASKQEKLPD | 871 | Q8NDH2 | |
| LDSESFLSKDPLHLK | 3116 | Q8NDH2 | |
| LGEESPSLHKRKREA | 441 | Q9NX74 | |
| ESLRSLAKHELAPAL | 911 | Q9Y613 | |
| ASPHASIKREKILAD | 461 | Q3B820 | |
| SLDSKVEREIPGKRH | 1431 | Q9Y238 | |
| SIVKELAKHTRLSPR | 416 | Q7Z3Z3 | |
| LKELHELLVVSSKPA | 356 | Q92681 | |
| DSAILEVRKESHPLA | 166 | Q9HBV2 | |
| VSIPSSDEHREKKKR | 16 | Q96BR1 | |
| LLSPATKEKLQREAH | 551 | P14778 | |
| REAPDTAEKAKSHLE | 111 | Q96CT7 | |
| AVDTKAPEKASIHRL | 331 | Q2VPK5 | |
| HPKAKLVLRIATDDS | 146 | P11926 | |
| ALALSRVELHKNPEK | 16 | Q96EK5 | |
| IADRLRDPDSHIVKK | 491 | Q96EK5 | |
| SEPRAKHSVKIRAAD | 286 | P15509 | |
| ALKHPATKDLAAAAA | 71 | Q8IU81 | |
| ALAIREKTLGKDHPA | 281 | Q07866 | |
| RTSIKDALDLIKAVH | 261 | Q8NGZ6 | |
| PDHSRALIKEKLTAD | 316 | O75928 | |
| TRDLSSSEPVHAKKR | 111 | Q8WTT2 | |
| IIKKTESDAALHPLL | 446 | Q07869 | |
| HLAKSKLEVFSPERL | 391 | Q86XP0 | |
| IDAKPTHELLTTKAD | 1361 | P22897 | |
| EHKKRIALEARPLLS | 1476 | Q9H1H9 | |
| KVDPRKDAHSTLLSK | 51 | Q9BPW8 | |
| PDHSSRELSKILAKL | 36 | Q9BYC5 | |
| LEPLKHVRFSAVKDE | 326 | Q9HCH5 | |
| DPSLEAHIKALKSLV | 236 | P59533 | |
| SLRSKKLKSEPHQVD | 296 | O75529 | |
| LTHLLLEKLKESAPS | 156 | Q8TC12 | |
| LSLTPRTEKIEVKHV | 56 | Q9NYK5 | |
| AHPNLVLSEDRKSVK | 346 | Q9HCM9 | |
| TIPKDIDLHLETKSV | 76 | Q8NDZ6 | |
| LAAKERTKSHVPSLL | 986 | Q5TCX8 | |
| HSSKLDPHKREVLLA | 66 | P58872 | |
| DAERRHKKLPLTALA | 61 | Q68EM7 | |
| SPAHLARELKELVKE | 876 | A1L390 | |
| SLTKLESSPRKLHKD | 1596 | Q9HCM1 | |
| LASKRRKLVAIVDPH | 456 | Q14697 | |
| AELRDDPIISTHLAK | 311 | O00231 | |
| DILPFDHSRVKLTLK | 66 | Q05209 | |
| KHSTARGLPLKEVLE | 561 | O43166 | |
| DLSKRSIHILPSSIK | 106 | Q9UQ13 | |
| TITELSPHLFKDLKL | 316 | Q8WXD0 | |
| REAESLIAKKIHPQT | 111 | P78371 | |
| APERAHLAKNLKLTE | 151 | Q99801 | |
| EAAKIPDKTERLHAL | 1356 | Q13017 | |
| DHSRALIKEKLTADP | 306 | O75925 | |
| LSAKVTLHREFPAKE | 201 | Q15198 | |
| SLALQPKLTRHKELA | 216 | Q86SQ0 | |
| SKRTKLGEKDLPHSV | 281 | Q86SQ0 | |
| LEVIEKARRSFPSKH | 186 | Q8TBJ4 | |
| VLASDVIHASRKDIP | 1146 | Q5VT25 | |
| PQKERKASLSLHVLE | 286 | Q9Y6L6 | |
| EPVLRKDLKEHLSAS | 146 | O00463 | |
| KVEPLDSLSLFHLKT | 1256 | Q8NFU7 | |
| DHKAAVPASEKLLLL | 586 | P28329 | |
| AKHLPKSTRDKVTDA | 766 | P42695 | |
| PSRTHLKVKTSDRDL | 11 | Q16281 | |
| VAHLPADELVSKKRN | 856 | O75153 | |
| HSTAEKAVDPKTRLL | 226 | O14730 | |
| NPDHSRALIKEKLTA | 296 | Q9Y6X2 | |
| SAHKGPDETLRIKAE | 301 | P22234 | |
| KTIDDIFKIAVHPLR | 881 | Q15111 | |
| TAQDPKLLVHLKATR | 481 | Q13435 | |
| SALRKHEIIHTGEKP | 466 | A8MXY4 | |
| KSEDFVKDSELHLPR | 1246 | Q9H9J4 | |
| SDLVKHLRVHTGEKP | 316 | Q96MX3 | |
| VEKRFPHDKLLLLDT | 211 | Q2NL82 | |
| VKVESALEVAHRLKP | 211 | Q9Y330 | |
| ASLERATLDFKPLHK | 216 | Q9NZ09 | |
| SPRHLIKEKRETATL | 36 | A0A0A6YYD4 | |
| DKHRRQLLKTESLPS | 1396 | Q13009 | |
| PTTDHIDTEKLKARE | 131 | O75663 | |
| LPEKVAKHVTLVRES | 16 | Q8WVD5 | |
| PRLKKSAHEIILDFI | 331 | Q08AE8 | |
| VEEVKRKHSAILASP | 51 | Q16623 | |
| PHSRETELKVHLKLV | 201 | O94964 | |
| EILERKTVLPSKHAV | 91 | Q8N0X2 | |
| RSLHPKTFEKLSRLE | 96 | Q7L0X0 | |
| IHSFELEKRLTLEPK | 446 | Q6IQ55 | |
| SERRPDITKLHAKVL | 61 | Q9HBL0 | |
| HLTASLEKPEVRKLA | 846 | Q9H5I5 | |
| VLPIASETLKHKSIE | 616 | Q3MJ13 | |
| DPRKFISLHRKALES | 2731 | Q6ZS81 | |
| LPTEKNIHEIRASKR | 56 | Q9NQX6 | |
| HALVIKTLPTKLRDA | 276 | Q8IZ13 | |
| AEVPTALEKIHRLSS | 166 | Q9BU02 | |
| KVRPTLADLHSFLKQ | 81 | P55017 | |
| ATAVLEHIKARKLDV | 406 | Q8WVM8 | |
| RHRPDLVDFSKLTKS | 221 | Q9H254 | |
| LLKPSHESRKDSAKR | 1316 | Q68DE3 | |
| HGEADRSTLKKALPT | 151 | P13994 | |
| LPHSKAKTRSRLEVA | 121 | O15213 | |
| TLSERVKLAEHKIFP | 971 | P22102 | |
| KLSRKHPELIDAAFT | 321 | Q6UW63 | |
| RPFSDSLHKSLTKIL | 366 | Q96JG9 | |
| AHLIVPEKIRSGDKS | 351 | Q96JL9 | |
| DKHALLDVTPSAIER | 671 | O95049 | |
| PRLHELIKLTASGDK | 201 | Q9H5U6 | |
| AHLLSKPFESLKLES | 206 | Q9UL58 | |
| LRSLKSKRPTEVAHA | 406 | Q6R2W3 | |
| DKVLTALSHKLEPAV | 841 | Q8N5H7 | |
| KLLTKDPESRVSSLH | 261 | Q9NY57 | |
| KDPASAKHSLLSARK | 1296 | Q70CQ4 | |
| RAPKADISKSLTHVS | 1076 | Q9BXT5 | |
| IGDRRVHADLLPSKK | 211 | Q8IWY8 | |
| LKREEPTDTLSKHQA | 251 | Q7RTV3 | |
| STKTLAKHRRVPLAD | 156 | P36406 | |
| VKRLSSLDDKIPHKS | 341 | Q96S53 | |
| ALHRLILPSEKFTSK | 1201 | A3KMH1 | |
| IFVHRDLAKDKPLSL | 86 | Q6PP77 | |
| ESHLKRNEASLPSIL | 576 | Q6N021 | |
| KDLAKLHREVRSTPL | 86 | Q9UEU0 | |
| PAETAHLRKELLIAA | 321 | Q9Y4A5 | |
| SSLKKHLRIHSDERP | 371 | Q9NTW7 | |
| DTKRPSSLAKHVDKV | 531 | Q9NTW7 | |
| SSQHLFLDLPKLEKR | 446 | P56192 | |
| SKRLEDQHRLLKPTA | 66 | Q8WY91 | |
| SLKHRDELLFVPAVK | 1056 | Q6PFW1 | |
| DRHSAIKLRPKEGET | 971 | Q9NYU2 | |
| DSHQLLDKRPKSESI | 651 | Q7Z570 | |
| FLVKHLSELLKSRPE | 166 | Q96NJ5 | |
| KTILEDEKRLAHPFS | 596 | P01130 | |
| PKRAKHSLLSGEEKE | 116 | P52179 | |
| HSEKRDKKSPLIEST | 291 | O14974 | |
| EAEHLVSKRKSHPLK | 66 | Q01538 |